Sihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express

08/14

Sihuan Pharmaceutical Holdings Group Ltd. has scheduled a board meeting for 26 August 2026.

The agenda includes: 1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026. 2. Authorising publication of the interim financial report. 3. Discussing and, if appropriate, approving the declaration and payment of an interim dividend.

The notice was signed by Chairman and Executive Director Dr. Che Fengsheng on 14 August 2026 in Hong Kong. The board currently comprises five executive directors—Dr. Che Fengsheng, Dr. Guo Weicheng, Dr. Zhang Jionglong, Ms. Chen Yanling and Ms. Miao Guili—and three independent non-executive directors—Mr. Tsang Wah Kwong, Dr. Zhu Xun and Mr. Wang Guan.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1120013894"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120013894\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120013894?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120013894","market":"us","top_or_hot":-1,"title":"Sihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>Sihuan Pharmaceutical Holdings Group Ltd. has scheduled a board meeting for 26 August 2026.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.  \n2. Authorising publication of the interim financial report.  \n3. Discussing and, if appropriate, approving the declaration and payment of an interim dividend.</p>\n<p>The notice was signed by Chairman and Executive Director Dr. Che Fengsheng on 14 August 2026 in Hong Kong. The board currently comprises five executive directors—Dr. Che Fengsheng, Dr. Guo Weicheng, Dr. Zhang Jionglong, Ms. Chen Yanling and Ms. Miao Guili—and three independent non-executive directors—Mr. Tsang Wah Kwong, Dr. Zhu Xun and Mr. Wang Guan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sihuan Pharmaceutical Holdings Group Ltd. has scheduled a board meeting for 26 August 2026.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.  \n2. Authorising publication of the interim financial report.  \n3. Discussing and, if appropriate, approving the declaration and payment of an interim dividend.</p>\n<p>The notice was signed by Chairman and Executive Director Dr. Che Fengsheng on 14 August 2026 in Hong Kong. The board currently comprises five executive directors—Dr. Che Fengsheng, Dr. Guo Weicheng, Dr. Zhang Jionglong, Ms. Chen Yanling and Ms. Miao Guili—and three independent non-executive directors—Mr. Tsang Wah Kwong, Dr. Zhu Xun and Mr. Wang Guan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00460","symbol_name":"四环医药","start_time":0,"source_url":"","article_id":"1120013894","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120013894","pubTimestamp":1786697306,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sihuan Pharmaceutical Holdings Group Ltd. has scheduled a board meeting for 26 August 2026. The agenda includes:   1. Reviewing and approving the consolidated interim results for the six months ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00460":"四环医药"},"translate_title":"四环制药将于 2026 年 8 月 26 日召开董事会会议，批准 2026 年上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00460":1},"content_text":"Sihuan Pharmaceutical Holdings Group Ltd. has scheduled a board meeting for 26 August 2026.\nThe agenda includes:  \n1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.  \n2. Authorising publication of the interim financial report.  \n3. Discussing and, if appropriate, approving the declaration and payment of an interim dividend.\nThe notice was signed by Chairman and Executive Director Dr. Che Fengsheng on 14 August 2026 in Hong Kong. The board currently comprises five executive directors—Dr. Che Fengsheng, Dr. Guo Weicheng, Dr. Zhang Jionglong, Ms. Chen Yanling and Ms. Miao Guili—and three independent non-executive directors—Mr. Tsang Wah Kwong, Dr. Zhu Xun and Mr. Wang Guan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}